APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibiotic API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antibiotic API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025190 pages

Choose your research edition.

Industry ResearchAntibiotic API Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibiotic API Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Antibiotic API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibiotic API Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibiotic API Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Antibiotic API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antibiotic API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antibiotic API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antibiotic API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antibiotic API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antibiotic API include UNITED LABORATORIES, HUAFANG PHARMACEUTICAL, Dongying Pharmaceutical, SALUBRIS, Shyndec Pharmaceutical, Dawnrays Pharmaceutical, CSPC, RUIYING PIONEER PHARMACEUTICAL and REYOUNG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antibiotic API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antibiotic API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antibiotic API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antibiotic API market size, projected growth trends, production technologies, key applications, and end-use industries.

Antibiotic API Segment by Company

UNITED LABORATORIES

HUAFANG PHARMACEUTICAL

Dongying Pharmaceutical

SALUBRIS

Shyndec Pharmaceutical

Dawnrays Pharmaceutical

CSPC

RUIYING PIONEER PHARMACEUTICAL

REYOUNG

QILU ANTIBIOTICS PHARMACEUTICAL

Novartis

LUKANG PHARMACEUTICAL

Medya Pharmaceutical

KELUN

North China Pharmaceutical

Harbin Pharmaceutical Group

FUKANG PHARMACEUTICAL

FUAN PHARMACEUTICAL

Orchid Pharma

Nectar Lifesciences

Centrient Pharmaceuticals

Aurobindo Pharma

ACS Dobfar

Antibiotic API Segment by Type

Aminoglycosides

Macrolides

Quinolones

Lincomycins

Penicillins

Tetracyclines

Cephalosporins

Others

Antibiotic API Segment by Application

Oral Medicine

Injection Medicine

Antibiotic API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotic API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibiotic API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotic API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antibiotic API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antibiotic API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antibiotic API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antibiotic API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antibiotic API Industry Trends Table 2. Antibiotic API Industry Drivers Table 3. Antibiotic API Industry Opportunities and Challenges Table 4. Antibiotic API Industry Restraints Table 5. Global Antibiotic API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antibiotic API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antibiotic API Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Antibiotic API Sales Market Share by Manufacturers Table 9. Global Antibiotic API Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Antibiotic API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antibiotic API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antibiotic API Manufacturers, Product Type & Application Table 13. Global Antibiotic API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antibiotic API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Aminoglycosides Table 17. Major Manufacturers of Macrolides Table 18. Major Manufacturers of Quinolones Table 19. Major Manufacturers of Lincomycins Table 20. Major Manufacturers of Penicillins Table 21. Major Manufacturers of Tetracyclines Table 22. Major Manufacturers of Cephalosporins Table 23. Major Manufacturers of Others Table 24. Global Antibiotic API Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Antibiotic API Sales by Type (2021-2026) & (Tons) Table 26. Global Antibiotic API Sales by Type (2027-2032) & (Tons) Table 27. Global Antibiotic API Sales Market Share by Type (2021-2026) Table 28. Global Antibiotic API Sales Market Share by Type (2027-2032) Table 29. Global Antibiotic API Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 30. Global Antibiotic API Revenue by Type (2021-2026) & (Tons) Table 31. Global Antibiotic API Revenue by Type (2027-2032) & (Tons) Table 32. Global Antibiotic API Revenue Market Share by Type (2021-2026) Table 33. Global Antibiotic API Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Oral Medicine Table 35. Major Manufacturers of Injection Medicine Table 36. Global Antibiotic API Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Antibiotic API Sales by Application (2021-2026) & (Tons) Table 38. Global Antibiotic API Sales by Application (2027-2032) & (Tons) Table 39. Global Antibiotic API Sales Market Share by Application (2021-2026) Table 40. Global Antibiotic API Sales Market Share by Application (2027-2032) Table 41. Global Antibiotic API Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 42. Global Antibiotic API Revenue by Application (2021-2026) & (Tons) Table 43. Global Antibiotic API Revenue by Application (2027-2032) & (Tons) Table 44. Global Antibiotic API Revenue Market Share by Application (2021-2026) Table 45. Global Antibiotic API Revenue Market Share by Application (2027-2032) Table 46. Global Antibiotic API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 47. Global Antibiotic API Sales by Region (2021-2026) & (Tons) Table 48. Global Antibiotic API Sales Market Share by Region (2021-2026) Table 49. Global Antibiotic API Sales Forecasted by Region (2027-2032) & (Tons) Table 50. Global Antibiotic API Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. North America Antibiotic API Sales by Country (2021-2026) & (Tons) Table 53. North America Antibiotic API Sales by Country (2027-2032) & (Tons) Table 54. Europe Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Europe Antibiotic API Sales by Country (2021-2026) & (Tons) Table 56. Europe Antibiotic API Sales by Country (2027-2032) & (Tons) Table 57. Asia Pacific Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. Asia Pacific Antibiotic API Sales by Country (2021-2026) & (Tons) Table 59. Asia Pacific Antibiotic API Sales by Country (2027-2032) & (Tons) Table 60. South America, Middle East and Africa Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 61. South America, Middle East and Africa Antibiotic API Sales by Country (2021-2026) & (Tons) Table 62. South America, Middle East and Africa Antibiotic API Sales by Country (2027-2032) & (Tons) Table 63. Global Antibiotic API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Antibiotic API Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Antibiotic API Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Antibiotic API Revenue Market Share by Region (2021-2026) Table 67. Global Antibiotic API Revenue Market Share by Region (2027-2032) Table 68. UNITED LABORATORIES Company Information Table 69. UNITED LABORATORIES Business Overview Table 70. UNITED LABORATORIES Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. UNITED LABORATORIES Antibiotic API Product Portfolio Table 72. UNITED LABORATORIES Recent Development Table 73. HUAFANG PHARMACEUTICAL Company Information Table 74. HUAFANG PHARMACEUTICAL Business Overview Table 75. HUAFANG PHARMACEUTICAL Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. HUAFANG PHARMACEUTICAL Antibiotic API Product Portfolio Table 77. HUAFANG PHARMACEUTICAL Recent Development Table 78. Dongying Pharmaceutical Company Information Table 79. Dongying Pharmaceutical Business Overview Table 80. Dongying Pharmaceutical Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dongying Pharmaceutical Antibiotic API Product Portfolio Table 82. Dongying Pharmaceutical Recent Development Table 83. SALUBRIS Company Information Table 84. SALUBRIS Business Overview Table 85. SALUBRIS Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. SALUBRIS Antibiotic API Product Portfolio Table 87. SALUBRIS Recent Development Table 88. Shyndec Pharmaceutical Company Information Table 89. Shyndec Pharmaceutical Business Overview Table 90. Shyndec Pharmaceutical Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shyndec Pharmaceutical Antibiotic API Product Portfolio Table 92. Shyndec Pharmaceutical Recent Development Table 93. Dawnrays Pharmaceutical Company Information Table 94. Dawnrays Pharmaceutical Business Overview Table 95. Dawnrays Pharmaceutical Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Dawnrays Pharmaceutical Antibiotic API Product Portfolio Table 97. Dawnrays Pharmaceutical Recent Development Table 98. CSPC Company Information Table 99. CSPC Business Overview Table 100. CSPC Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. CSPC Antibiotic API Product Portfolio Table 102. CSPC Recent Development Table 103. RUIYING PIONEER PHARMACEUTICAL Company Information Table 104. RUIYING PIONEER PHARMACEUTICAL Business Overview Table 105. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Portfolio Table 107. RUIYING PIONEER PHARMACEUTICAL Recent Development Table 108. REYOUNG Company Information Table 109. REYOUNG Business Overview Table 110. REYOUNG Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. REYOUNG Antibiotic API Product Portfolio Table 112. REYOUNG Recent Development Table 113. QILU ANTIBIOTICS PHARMACEUTICAL Company Information Table 114. QILU ANTIBIOTICS PHARMACEUTICAL Business Overview Table 115. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Portfolio Table 117. QILU ANTIBIOTICS PHARMACEUTICAL Recent Development Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Novartis Antibiotic API Product Portfolio Table 122. Novartis Recent Development Table 123. LUKANG PHARMACEUTICAL Company Information Table 124. LUKANG PHARMACEUTICAL Business Overview Table 125. LUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. LUKANG PHARMACEUTICAL Antibiotic API Product Portfolio Table 127. LUKANG PHARMACEUTICAL Recent Development Table 128. Medya Pharmaceutical Company Information Table 129. Medya Pharmaceutical Business Overview Table 130. Medya Pharmaceutical Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Medya Pharmaceutical Antibiotic API Product Portfolio Table 132. Medya Pharmaceutical Recent Development Table 133. KELUN Company Information Table 134. KELUN Business Overview Table 135. KELUN Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. KELUN Antibiotic API Product Portfolio Table 137. KELUN Recent Development Table 138. North China Pharmaceutical Company Information Table 139. North China Pharmaceutical Business Overview Table 140. North China Pharmaceutical Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. North China Pharmaceutical Antibiotic API Product Portfolio Table 142. North China Pharmaceutical Recent Development Table 143. Harbin Pharmaceutical Group Company Information Table 144. Harbin Pharmaceutical Group Business Overview Table 145. Harbin Pharmaceutical Group Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Harbin Pharmaceutical Group Antibiotic API Product Portfolio Table 147. Harbin Pharmaceutical Group Recent Development Table 148. FUKANG PHARMACEUTICAL Company Information Table 149. FUKANG PHARMACEUTICAL Business Overview Table 150. FUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. FUKANG PHARMACEUTICAL Antibiotic API Product Portfolio Table 152. FUKANG PHARMACEUTICAL Recent Development Table 153. FUAN PHARMACEUTICAL Company Information Table 154. FUAN PHARMACEUTICAL Business Overview Table 155. FUAN PHARMACEUTICAL Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. FUAN PHARMACEUTICAL Antibiotic API Product Portfolio Table 157. FUAN PHARMACEUTICAL Recent Development Table 158. Orchid Pharma Company Information Table 159. Orchid Pharma Business Overview Table 160. Orchid Pharma Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Orchid Pharma Antibiotic API Product Portfolio Table 162. Orchid Pharma Recent Development Table 163. Nectar Lifesciences Company Information Table 164. Nectar Lifesciences Business Overview Table 165. Nectar Lifesciences Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Nectar Lifesciences Antibiotic API Product Portfolio Table 167. Nectar Lifesciences Recent Development Table 168. Centrient Pharmaceuticals Company Information Table 169. Centrient Pharmaceuticals Business Overview Table 170. Centrient Pharmaceuticals Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Centrient Pharmaceuticals Antibiotic API Product Portfolio Table 172. Centrient Pharmaceuticals Recent Development Table 173. Aurobindo Pharma Company Information Table 174. Aurobindo Pharma Business Overview Table 175. Aurobindo Pharma Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Aurobindo Pharma Antibiotic API Product Portfolio Table 177. Aurobindo Pharma Recent Development Table 178. ACS Dobfar Company Information Table 179. ACS Dobfar Business Overview Table 180. ACS Dobfar Antibiotic API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. ACS Dobfar Antibiotic API Product Portfolio Table 182. ACS Dobfar Recent Development Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Antibiotic API Distributors List Table 186. Antibiotic API Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Antibiotic API Product Image Figure 2. Global Antibiotic API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibiotic API Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibiotic API Sales (2021-2032) & (Tons) Figure 5. Global Antibiotic API Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Antibiotic API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Aminoglycosides Image Figure 9. Macrolides Image Figure 10. Quinolones Image Figure 11. Lincomycins Image Figure 12. Penicillins Image Figure 13. Tetracyclines Image Figure 14. Cephalosporins Image Figure 15. Others Image Figure 16. Global Antibiotic API Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 17. Global Antibiotic API Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Antibiotic API Sales Market Share by Type (2021-2032) Figure 19. Global Antibiotic API Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Antibiotic API Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antibiotic API Revenue Market Share by Type (2021-2032) Figure 22. Oral Medicine Image Figure 23. Injection Medicine Image Figure 24. Global Antibiotic API Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Antibiotic API Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Antibiotic API Sales Market Share by Application (2021-2032) Figure 27. Global Antibiotic API Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 28. Global Antibiotic API Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Antibiotic API Revenue Market Share by Application (2021-2032) Figure 30. North America Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 31. North America Antibiotic API Sales Market Share by Country (2021-2032) Figure 32. U.S. Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 33. Canada Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Mexico Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Europe Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Europe Antibiotic API Sales Market Share by Country (2021-2032) Figure 37. Germany Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 38. France Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 39. U.K. Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Italy Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Netherlands Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Asia Pacific Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Asia Pacific Antibiotic API Sales Market Share by Country (2021-2032) Figure 44. China Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 45. Japan Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South Korea Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 47. Southeast Asia Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 48. India Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Australia Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 50. South America, Middle East and Africa Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 51. South America, Middle East and Africa Antibiotic API Sales Market Share by Country (2021-2032) Figure 52. Brazil Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 53. South Africa Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Saudi Arabia Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Turkey Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Argentina Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 57. UAE Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 58. Egypt Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 59. Chile Antibiotic API Sales and Growth Rate (2021-2032) & (Tons) Figure 60. Global Antibiotic API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Antibiotic API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Antibiotic API Revenue (2021-2032) & (US$ Million) Figure 63. North America Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Antibiotic API Revenue (2021-2032) & (US$ Million) Figure 65. Europe Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Antibiotic API Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Antibiotic API Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Antibiotic API Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Antibiotic API Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Aminoglycosides
  • Macrolides
  • Quinolones
  • Lincomycins
  • Penicillins
  • Tetracyclines
  • Cephalosporins
  • Others
Applications
  • Oral Medicine
  • Injection Medicine
Companies covered
  • UNITED LABORATORIES
  • HUAFANG PHARMACEUTICAL
  • Dongying Pharmaceutical
  • SALUBRIS
  • Shyndec Pharmaceutical
  • Dawnrays Pharmaceutical
  • CSPC
  • RUIYING PIONEER PHARMACEUTICAL
  • REYOUNG
  • QILU ANTIBIOTICS PHARMACEUTICAL
  • Novartis
  • LUKANG PHARMACEUTICAL
  • Medya Pharmaceutical
  • KELUN
  • North China Pharmaceutical
  • Harbin Pharmaceutical Group
  • FUKANG PHARMACEUTICAL
  • FUAN PHARMACEUTICAL
  • Orchid Pharma
  • Nectar Lifesciences
  • Centrient Pharmaceuticals
  • Aurobindo Pharma
  • ACS Dobfar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antibiotic API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antibiotic API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antibiotic API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antibiotic API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antibiotic API Market Dynamics
  1. 2.1 Antibiotic API Industry Trends
  2. 2.2 Antibiotic API Industry Drivers
  3. 2.3 Antibiotic API Industry Opportunities and Challenges
  4. 2.4 Antibiotic API Industry Restraints
3 Antibiotic API Market by Manufacturers
  1. 3.1 Global Antibiotic API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antibiotic API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antibiotic API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antibiotic API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antibiotic API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antibiotic API Manufacturers, Product Type & Application
  7. 3.7 Global Antibiotic API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antibiotic API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antibiotic API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antibiotic API Tier 1, Tier 2, and Tier 3
4 Antibiotic API Market by Type
  1. 4.1 Antibiotic API Type Introduction
  2. 4.1.1 Aminoglycosides
  3. 4.1.2 Macrolides
  4. 4.1.3 Quinolones
  5. 4.1.4 Lincomycins
  6. 4.1.5 Penicillins
  7. 4.1.6 Tetracyclines
  8. 4.1.7 Cephalosporins
  9. 4.1.8 Others
  10. 4.2 Global Antibiotic API Sales by Type
  11. 4.2.1 Global Antibiotic API Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Antibiotic API Sales by Type (2021-2032)
  13. 4.2.3 Global Antibiotic API Sales Market Share by Type (2021-2032)
  14. 4.3 Global Antibiotic API Revenue by Type
  15. 4.3.1 Global Antibiotic API Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Antibiotic API Revenue by Type (2021-2032)
  17. 4.3.3 Global Antibiotic API Revenue Market Share by Type (2021-2032)
5 Antibiotic API Market by Application
  1. 5.1 Antibiotic API Application Introduction
  2. 5.1.1 Oral Medicine
  3. 5.1.2 Injection Medicine
  4. 5.2 Global Antibiotic API Sales by Application
  5. 5.2.1 Global Antibiotic API Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antibiotic API Sales by Application (2021-2032)
  7. 5.2.3 Global Antibiotic API Sales Market Share by Application (2021-2032)
  8. 5.3 Global Antibiotic API Revenue by Application
  9. 5.3.1 Global Antibiotic API Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antibiotic API Revenue by Application (2021-2032)
  11. 5.3.3 Global Antibiotic API Revenue Market Share by Application (2021-2032)
6 Global Antibiotic API Sales by Region
  1. 6.1 Global Antibiotic API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antibiotic API Sales by Region (2021-2032)
  3. 6.2.1 Global Antibiotic API Sales by Region (2021-2026)
  4. 6.2.2 Global Antibiotic API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antibiotic API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antibiotic API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antibiotic API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antibiotic API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antibiotic API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antibiotic API Revenue by Region
  1. 7.1 Global Antibiotic API Revenue by Region
  2. 7.1.1 Global Antibiotic API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antibiotic API Revenue by Region (2021-2026)
  4. 7.1.3 Global Antibiotic API Revenue by Region (2027-2032)
  5. 7.1.4 Global Antibiotic API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antibiotic API Revenue (2021-2032)
  8. 7.2.2 North America Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antibiotic API Revenue (2021-2032)
  11. 7.3.2 Europe Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antibiotic API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antibiotic API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antibiotic API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 UNITED LABORATORIES
  2. 8.1.1 UNITED LABORATORIES Company Information
  3. 8.1.2 UNITED LABORATORIES Business Overview
  4. 8.1.3 UNITED LABORATORIES Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 UNITED LABORATORIES Antibiotic API Product Portfolio
  6. 8.1.5 UNITED LABORATORIES Recent Developments
  7. 8.2 HUAFANG PHARMACEUTICAL
  8. 8.2.1 HUAFANG PHARMACEUTICAL Company Information
  9. 8.2.2 HUAFANG PHARMACEUTICAL Business Overview
  10. 8.2.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 HUAFANG PHARMACEUTICAL Antibiotic API Product Portfolio
  12. 8.2.5 HUAFANG PHARMACEUTICAL Recent Developments
  13. 8.3 Dongying Pharmaceutical
  14. 8.3.1 Dongying Pharmaceutical Company Information
  15. 8.3.2 Dongying Pharmaceutical Business Overview
  16. 8.3.3 Dongying Pharmaceutical Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dongying Pharmaceutical Antibiotic API Product Portfolio
  18. 8.3.5 Dongying Pharmaceutical Recent Developments
  19. 8.4 SALUBRIS
  20. 8.4.1 SALUBRIS Company Information
  21. 8.4.2 SALUBRIS Business Overview
  22. 8.4.3 SALUBRIS Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SALUBRIS Antibiotic API Product Portfolio
  24. 8.4.5 SALUBRIS Recent Developments
  25. 8.5 Shyndec Pharmaceutical
  26. 8.5.1 Shyndec Pharmaceutical Company Information
  27. 8.5.2 Shyndec Pharmaceutical Business Overview
  28. 8.5.3 Shyndec Pharmaceutical Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shyndec Pharmaceutical Antibiotic API Product Portfolio
  30. 8.5.5 Shyndec Pharmaceutical Recent Developments
  31. 8.6 Dawnrays Pharmaceutical
  32. 8.6.1 Dawnrays Pharmaceutical Company Information
  33. 8.6.2 Dawnrays Pharmaceutical Business Overview
  34. 8.6.3 Dawnrays Pharmaceutical Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dawnrays Pharmaceutical Antibiotic API Product Portfolio
  36. 8.6.5 Dawnrays Pharmaceutical Recent Developments
  37. 8.7 CSPC
  38. 8.7.1 CSPC Company Information
  39. 8.7.2 CSPC Business Overview
  40. 8.7.3 CSPC Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSPC Antibiotic API Product Portfolio
  42. 8.7.5 CSPC Recent Developments
  43. 8.8 RUIYING PIONEER PHARMACEUTICAL
  44. 8.8.1 RUIYING PIONEER PHARMACEUTICAL Company Information
  45. 8.8.2 RUIYING PIONEER PHARMACEUTICAL Business Overview
  46. 8.8.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Portfolio
  48. 8.8.5 RUIYING PIONEER PHARMACEUTICAL Recent Developments
  49. 8.9 REYOUNG
  50. 8.9.1 REYOUNG Company Information
  51. 8.9.2 REYOUNG Business Overview
  52. 8.9.3 REYOUNG Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 REYOUNG Antibiotic API Product Portfolio
  54. 8.9.5 REYOUNG Recent Developments
  55. 8.10 QILU ANTIBIOTICS PHARMACEUTICAL
  56. 8.10.1 QILU ANTIBIOTICS PHARMACEUTICAL Company Information
  57. 8.10.2 QILU ANTIBIOTICS PHARMACEUTICAL Business Overview
  58. 8.10.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Portfolio
  60. 8.10.5 QILU ANTIBIOTICS PHARMACEUTICAL Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Antibiotic API Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 LUKANG PHARMACEUTICAL
  68. 8.12.1 LUKANG PHARMACEUTICAL Company Information
  69. 8.12.2 LUKANG PHARMACEUTICAL Business Overview
  70. 8.12.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 LUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
  72. 8.12.5 LUKANG PHARMACEUTICAL Recent Developments
  73. 8.13 Medya Pharmaceutical
  74. 8.13.1 Medya Pharmaceutical Company Information
  75. 8.13.2 Medya Pharmaceutical Business Overview
  76. 8.13.3 Medya Pharmaceutical Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medya Pharmaceutical Antibiotic API Product Portfolio
  78. 8.13.5 Medya Pharmaceutical Recent Developments
  79. 8.14 KELUN
  80. 8.14.1 KELUN Company Information
  81. 8.14.2 KELUN Business Overview
  82. 8.14.3 KELUN Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 KELUN Antibiotic API Product Portfolio
  84. 8.14.5 KELUN Recent Developments
  85. 8.15 North China Pharmaceutical
  86. 8.15.1 North China Pharmaceutical Company Information
  87. 8.15.2 North China Pharmaceutical Business Overview
  88. 8.15.3 North China Pharmaceutical Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 North China Pharmaceutical Antibiotic API Product Portfolio
  90. 8.15.5 North China Pharmaceutical Recent Developments
  91. 8.16 Harbin Pharmaceutical Group
  92. 8.16.1 Harbin Pharmaceutical Group Company Information
  93. 8.16.2 Harbin Pharmaceutical Group Business Overview
  94. 8.16.3 Harbin Pharmaceutical Group Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Harbin Pharmaceutical Group Antibiotic API Product Portfolio
  96. 8.16.5 Harbin Pharmaceutical Group Recent Developments
  97. 8.17 FUKANG PHARMACEUTICAL
  98. 8.17.1 FUKANG PHARMACEUTICAL Company Information
  99. 8.17.2 FUKANG PHARMACEUTICAL Business Overview
  100. 8.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 FUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
  102. 8.17.5 FUKANG PHARMACEUTICAL Recent Developments
  103. 8.18 FUAN PHARMACEUTICAL
  104. 8.18.1 FUAN PHARMACEUTICAL Company Information
  105. 8.18.2 FUAN PHARMACEUTICAL Business Overview
  106. 8.18.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 FUAN PHARMACEUTICAL Antibiotic API Product Portfolio
  108. 8.18.5 FUAN PHARMACEUTICAL Recent Developments
  109. 8.19 Orchid Pharma
  110. 8.19.1 Orchid Pharma Company Information
  111. 8.19.2 Orchid Pharma Business Overview
  112. 8.19.3 Orchid Pharma Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Orchid Pharma Antibiotic API Product Portfolio
  114. 8.19.5 Orchid Pharma Recent Developments
  115. 8.20 Nectar Lifesciences
  116. 8.20.1 Nectar Lifesciences Company Information
  117. 8.20.2 Nectar Lifesciences Business Overview
  118. 8.20.3 Nectar Lifesciences Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Nectar Lifesciences Antibiotic API Product Portfolio
  120. 8.20.5 Nectar Lifesciences Recent Developments
  121. 8.21 Centrient Pharmaceuticals
  122. 8.21.1 Centrient Pharmaceuticals Company Information
  123. 8.21.2 Centrient Pharmaceuticals Business Overview
  124. 8.21.3 Centrient Pharmaceuticals Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Centrient Pharmaceuticals Antibiotic API Product Portfolio
  126. 8.21.5 Centrient Pharmaceuticals Recent Developments
  127. 8.22 Aurobindo Pharma
  128. 8.22.1 Aurobindo Pharma Company Information
  129. 8.22.2 Aurobindo Pharma Business Overview
  130. 8.22.3 Aurobindo Pharma Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Aurobindo Pharma Antibiotic API Product Portfolio
  132. 8.22.5 Aurobindo Pharma Recent Developments
  133. 8.23 ACS Dobfar
  134. 8.23.1 ACS Dobfar Company Information
  135. 8.23.2 ACS Dobfar Business Overview
  136. 8.23.3 ACS Dobfar Antibiotic API Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 ACS Dobfar Antibiotic API Product Portfolio
  138. 8.23.5 ACS Dobfar Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antibiotic API Value Chain Analysis
  2. 9.1.1 Antibiotic API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antibiotic API Production Mode & Process
  6. 9.2 Antibiotic API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antibiotic API Distributors
  9. 9.2.3 Antibiotic API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst